Financial Performance 2009

In Australia Bayer posted growth of just under one percent. This was driven by a strong performance in our HealthCare business. Within this sector all three divisions – Bayer Schering Pharma, Bayer Consumer Care and Bayer Animal Health - delivered good growth of around six percent each.

Whilst Bayer CropScience performance in Australia was hampered by the relentless drought, the successful implementation of a business strategy that will reduce exposure to market segments directly affected by drought sees the subgroup well placed for future success.

Bayer MaterialScience in Australia fared better than could be expected given the dramatic downturn in the manufacturing industry globally. The successful merger of Bayer MaterialScience with Laserlite Pty Ltd to create a new legal entity, Bayer MaterialScience Pty Ltd, in July 2009, forms a strong basis for the forthcoming year.

In New Zealand tough market conditions in the manufacturing and agricultural sectors were reflected in the results of Bayer MaterialScience and Bayer CropScience respectively. In a similar pattern to Australia, it was the Bayer HealthCare subgroup with increased sales of seven percent over 2008 that ensured an overall positive financial end to the company in 2009.

The graphs below provide a clear picture of the financial results delivered in Bayer Australia and New Zealand in 2009.

For information on Bayer AG financial results please click here.